Literature DB >> 21618456

Integrated approach to produce a recombinant, His-tagged human α-galactosidase A in mammalian cells.

José Luis Corchero1, Rosa Mendoza, Julia Lorenzo, Victor Rodríguez-Sureda, Carmen Domínguez, Esther Vázquez, Neus Ferrer-Miralles, Antonio Villaverde.   

Abstract

Successful production of recombinant proteins (r-proteins) by transient gene expression (TGE) depends on several parameters (including producer cells, culture conditions, transfection procedure, or expression vector) that should be optimized when producing any recombinant product. In this work, TGE-based production of human α-galactosidase A (GLA) is described. Producer cells, expression vectors, and parameters influencing cell metabolism after transfection have been tested. The enzyme is secreted, has the right molecular weight, and is enzymatically active. Productivities of up to 30-40 mg/L have been achieved, with a simple, fast procedure. A 6 × His tag allows enzyme purification in a single step, rendering a highly pure product. We propose a TGE-based protocol able to produce up to several milligrams per liter of highly pure, active GLA in a time as short as a few days. By this, enough amounts of engineered versions of the enzyme can be easily produced to be tested in vitro or in preclinical trials.
Copyright © 2011 American Institute of Chemical Engineers (AIChE).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21618456     DOI: 10.1002/btpr.637

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  1 in total

Review 1.  Production of Therapeutic Enzymes by Lentivirus Transgenesis.

Authors:  María Celeste Rodríguez; Natalia Ceaglio; Sebastián Antuña; María Belén Tardivo; Marina Etcheverrigaray; Claudio Prieto
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.